Thursday, October 17, 2013

Biodesy Gets $15M For Protein Analysis Tools

Burlingame-based Biodesy has raised $15M in a funding round, for its protein analysis systems, the company said this week. According to the company, the Series A funding came from 5AM Ventures, Pfizer Venture Investments, and Roche Venture Fund. Biodesy said the new funding will go to further develop and commercialize its platform, which enables real-time measurement of protein conformational change. The company also appointed Greg Yap as CEO and Director of the company; Yap was previously Entrepreneur in Residence at GE. More information »